Skip to main content

Trump's Surgeon General Pick Touts Psychedelics for Health

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on May 15, 2025.

via HealthDay

THURSDAY, May 15, 2025 — President Donald Trump's choice for U.S. surgeon general has raised eyebrows for promoting the use of psychedelic drugs, such as psilocybin, in a 2024 book and her personal newsletter.

His choice for the post is wellness influencer Dr. Casey Means, who was recommended by Health and Human Services Secretary Robert F. Kennedy Jr.

Means' promotion of psilocybin-assisted therapy is noteworthy because psilocybin is illegal under federal law.

Psilocybin, the active ingredient in psychedelic mushrooms, is classified as a Schedule 1 drug, meaning it has no accepted medical use and a high potential for abuse, The Associated Press reported.

Oregon and Colorado have legalized some forms of psychedelic therapy.

Means, who holds degrees from Stanford University, began a medical residency in Oregon but never finished it. Her medical license is inactive, The AP said.

The role of surgeon general? Offer the best science-based advice on public health.

Past surgeons general have addressed concerns like AIDS, smoking and suicide prevention.

Trump said he selected Means for the role because HHS Secretary Kennedy "thought she was fantastic," adding that he, himself, didn't know her.

In her 2024 book "Good Energy," Means encouraged readers to consider "psilocybin-assisted therapy.”

“Strong scientific evidence suggests that this psychedelic therapy can be one of the most meaningful experiences of life for some people, as they have been for me,” she wrote.

Means also described her personal experience with psilocybin in 2021.

“Psilocybin can be a doorway to a different reality that is free from the limiting beliefs of my ego, feelings, and personal history,” she wrote.

Means has referred to psychedelics as “plant medicine.” In an October newsletter, she mentioned using psychedelics to help her make “space to find love at 35," The Associated Press reported.

While some research suggests psychedelics may help treat certain mental health conditions, experts warn that the risks are real. Psilocybin can cause hallucinations, nausea, headaches and increased heart rate.

Further, taking the drug unsupervised can be dangerous.

Means also praised MDMA (ecstasy) as a potential therapy for PTSD. However, in 2024, the U.S. Food and Drug Administration (FDA) declined to approve MDMA as a treatment because of safety concerns and what it termed poor-quality research.

Means’ brother, Calley Means, a health adviser in the Trump administration, has also spoken about his personal use of psilocybin. He said the experience was life-changing and he later invested heavily in companies developing psychedelic treatments, The Associated Press reported.

Sources

  • The Associated Press, May 14, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Recalled: More Than 67,000 Cases of Deodorant Sold at Dollar Tree, Walmart, and Amazon

TUESDAY, July 22, 2025 — More than 67,000 cases of Power Stick deodorant have been recalled due to an undisclosed manufacturing issue. The recalled deodorants, made by A.P...

Dogs Can Sniff Out Parkinson's Disease, Study Shows

TUESDAY, July 22, 2025 — Dogs’ noses are sensitive enough to track down fleeing convicts, locate human remains in hidden burial sites and detect illicit drug...

For Some, Gluten Intolerance Is Psychological, Study Says

TUESDAY, July 22, 2025 — Gluten intolerance might be all in the minds of some people with irritable bowel syndrome (IBS), results from a small-scale experiment...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.